Syncromune Presents Ph1 SV-102 Prostate Cancer Data At ASCO
02 Jun 2025 //
GLOBENEWSWIRE
Syncromune Announces 1st Patient Dosed in LEGION-100 Ph 2a Trial
30 May 2025 //
GLOBENEWSWIRE
Syncromune Announces Abstract on SYNC-T Therapy SV-102 Phase
23 May 2025 //
GLOBENEWSWIRE
Syncromune to Present Clinical Data from SV-102 Phase 1 Trial
25 Apr 2025 //
GLOBENEWSWIRE
Syncromune Appoints Zhihong Li as Chief Regulatory Affair Officer
25 Mar 2025 //
GLOBENEWSWIRE